Treatment of Iron-Loaded Veterinary Sarcoma by Artemisia annua

被引:31
作者
Breuer E. [1 ]
Efferth T. [2 ]
机构
[1] Veterinary Clinic for Pets, Müllheim/Baden
[2] Department of Pharmaceutical Biology, Institute of Pharmacy and Biochemistry, Johannes Gutenberg University, Mainz
关键词
Artemisinin; Asteraceae; Comparative oncology; Scopoletin; Veterinary cancer;
D O I
10.1007/s13659-014-0013-7
中图分类号
学科分类号
摘要
Artemisinin, a constituent of Artemisia annua L., is a well-known antimalarial drug. Artemisinin-type drugs also inhibit cancer growth in vitro and in vivo. Herbal extracts of A.annua inhibit the growth of cancer cell lines. Here, we report on the use of capsules containing powder of Herba Artemisiae annuae to treat pet sarcoma. The surgical tumor removal as standard treatment was supplemented by adjuvant therapy with A.annua. One cat and one dog with fibrosarcoma survived 40 and 37 months, respectively, without tumor relapse. Two other dogs suffering from fibrosarcoma and hemangioendothelial sarcoma also showed complete remission and are still alive after 39 and 26 months, respectively. A.annua was well tolerated without noticeable side effects. These four cases indicate that A.annua may be a promising herbal drug for cancer therapy. © 2014, The Author(s).
引用
收藏
页码:113 / 118
页数:5
相关论文
共 82 条
[1]  
Klayman D.L., Science, 228, pp. 1049-1055, (1985)
[2]  
Efferth T., Planta Med., 73, pp. 299-309, (2007)
[3]  
Sun W.S., Han J.X., Yang W.Y., Deng D.A., Yue X.F., Acta Pharmacol. Sin., 13, pp. 541-543, (1992)
[4]  
Woerdenbag H.J., Moskal T.A., Pras N., Malingre T.M., el-Feraly F.S., Kampinga H.H., Konings A.W., J. Nat. Prod., 56, pp. 845-849, (1993)
[5]  
Zheng G.Q., Planta Med., 60, pp. 54-57, (1994)
[6]  
Moore J.C., Lai H., Li J.R., Ren R.L., McDougall J.A., Singh N.P., Chou C.K., Cancer Lett., 98, pp. 83-87, (1995)
[7]  
Efferth T., Rucker G., Falkenberg M., Manns D., Olbrich A., Fabry U., Osieka R., Arzneim. Forsch., 46, pp. 196-200, (1996)
[8]  
Efferth T., Dunstan H., Sauerbrey A., Miyachi H., Chitambar C.R., Int. J. Oncol., 18, pp. 767-773, (2001)
[9]  
Efferth T., Drug Resist. Updat., 8, pp. 85-97, (2005)
[10]  
Efferth T., Curr. Drug Targets, 7, pp. 407-421, (2006)